sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 11, 2026

Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars

View original at globenewswire.com
Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars LONDON, Ontario, 11 juin 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The LIFE offering is also expected to close on or about the public offering closing date, or at any other date determined by the Company, but no later than 45 days from the date of the press release. The LIFE offering may be completed in one or more tranches.

    60% confidence
  • Certain insiders of the Company may participate in the LIFE offering, and any such participation will constitute a 'related-party transaction' under Multilateral Instrument 61-101, but the Company expects to rely on exemptions from formal valuation and minority shareholder approval requirements because neither the fair market value of the LIFE shares subscribed by insiders nor the consideration paid will exceed 25% of the Company's market capitalization.

    60% confidence
  • Aduro's Hydrochemolytic technology uses water as a key agent in a chemical platform operating at relatively low temperatures and costs, enabling the recycling of low-value feedstocks into 21st-century resources.

    60% confidence
  • Aduro intends to use the net proceeds of the offering to fund expenses related to the design, engineering, and construction of its first commercial-scale industrial demonstration plant (FOAK Plant), to continue its research and development activities, and for general corporate purposes and working capital.

    60% confidence
  • The USD/CAD exchange rate published by the Bank of Canada on June 9, 2026 was 1 USD = 1.3947 CAD.

    60% confidence
  • Closing of the public offering is expected on or about June 11, 2026, subject to customary closing conditions including listing of offered shares on TSX and Nasdaq and receipt of required exchange approvals.

    60% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · gross proceeds life offering max7169810 USD
Aduro Clean Technologies Inc. · total gross proceeds max22805214 USD
Aduro Clean Technologies Inc. · stock price15.20 USD
Aduro Clean Technologies Inc. · stock price cad21.20 CAD
Aduro Clean Technologies Inc. · shares offered life max471698 shares
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Aduro Clean Technologies annonce le lancement d’une offre publique souscrite d’un montant de 15,64 millions de dollars et d’un placement privé concomitant pouvant atteindre 7,17 millions de dollars — Source | Via News | pt.VIA.NEWS